Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Histopathology|March 4, 2008
The potential role of ER beta isoforms in the clinical management of breast cancerC A Green, M B Peter, V Speirs, et al.British Journal of Cancer|June 11, 2009
Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissueM P Charalambous, T Lightfoot, V Speirs, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 2, 2005
Steroid hormone receptor expression in male breast cancerC E Murphy, P J Carder, M R J Lansdown, et al.International Journal of Oncology|June 22, 1999
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breastD Chakravarthy, A R Green, V L Green, et al.Cancer Research|December 20, 1999
Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patientsV Speirs, C Malone, D S Walton, et al.The Anatomical Record|May 1, 1993
Cell biology of pulmonary neuroepithelial bodies--validation of an in vitro model. I. Effects of hypoxia and Ca2+ ionophore on serotonin content and exocytosis of dense core vesiclesE Cutz, V Speirs, H Yeger, et al.International Journal of Oncology|August 3, 2007
Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitroD J Scott, A T Parkes, F Ponchel, et al.Neuroscience Letters|March 28, 1994
Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitroE Boyle-Walsh, I A Hashim, V Speirs, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomasV L Green, V Speirs, A M Landolt, et al.The Journal of Endocrinology|May 13, 1999
Functional inactivation of the oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen speciesC J Newton, N Drummond, C H Burgoyne, et al.Pageof 6